See more : Earum Pharmaceuticals Limited (EARUM.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Danimer Scientific, Inc. (DNMR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danimer Scientific, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- BlackRock, Inc. (BLK.SW) Income Statement Analysis – Financial Results
- TUS ENVIRONMENTAL SCIENCE AND TECHNOLOGY DEVELOPMENT Co., LTD. (000826.SZ) Income Statement Analysis – Financial Results
- Aprogen pharmaceuticals,Inc. (003060.KS) Income Statement Analysis – Financial Results
- LXI REIT plc (LXI.L) Income Statement Analysis – Financial Results
- Yi Jinn Industrial Co., Ltd. (1457.TW) Income Statement Analysis – Financial Results
Danimer Scientific, Inc. (DNMR)
About Danimer Scientific, Inc.
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 46.68M | 53.22M | 58.75M | 47.33M | 32.34M | 30.45M |
Cost of Revenue | 73.64M | 63.63M | 57.87M | 35.88M | 21.24M | 19.21M |
Gross Profit | -26.96M | -10.41M | 884.00K | 11.46M | 11.11M | 11.25M |
Gross Profit Ratio | -57.75% | -19.57% | 1.50% | 24.21% | 34.34% | 36.92% |
Research & Development | 29.24M | 31.94M | 20.27M | 7.85M | 5.48M | 5.14M |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.26M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K |
SG&A | 68.98M | 81.59M | 80.00M | 19.34M | 16.03M | 7.36M |
Other Expenses | 434.00K | 723.00K | -44.00K | -31.00K | 277.00K | 0.00 |
Operating Expenses | 98.66M | 113.53M | 100.27M | 27.19M | 21.51M | 8.11M |
Cost & Expenses | 172.30M | 177.16M | 158.14M | 63.07M | 42.75M | 27.32M |
Interest Income | 0.00 | 1.72M | 763.00K | 347.00K | 340.00K | 2.88M |
Interest Expense | 0.00 | 112.25M | 763.00K | 2.43M | 3.48M | 0.00 |
Depreciation & Amortization | 29.06M | 20.09M | 11.67M | 4.61M | 3.51M | 3.54M |
EBITDA | -96.46M | -103.49M | -87.72M | -10.30M | -6.90M | 2.35M |
EBITDA Ratio | -206.61% | -90.63% | -151.15% | -21.76% | -12.87% | 7.70% |
Operating Income | -125.62M | -187.43M | -99.39M | -15.74M | -10.40M | -1.19M |
Operating Income Ratio | -269.08% | -352.20% | -169.18% | -33.25% | -32.16% | -3.91% |
Total Other Income/Expenses | -29.54M | 6.87M | 26.13M | 6.88M | -5.03M | -2.91M |
Income Before Tax | -155.15M | -180.57M | -73.34M | -12.57M | -15.43M | 259.00K |
Income Before Tax Ratio | -332.35% | -339.30% | -124.84% | -26.56% | -47.70% | 0.85% |
Income Tax Expense | 319.00K | -810.00K | -13.23M | 2.40M | 4.09M | 51.00K |
Net Income | -155.47M | -179.76M | -60.11M | -14.97M | -19.51M | 208.00K |
Net Income Ratio | -333.03% | -337.78% | -102.31% | -31.62% | -60.33% | 0.68% |
EPS | -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
EPS Diluted | -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
Weighted Avg Shares Out | 102.00M | 101.10M | 93.08M | 84.54M | 25.37M | 2.97M |
Weighted Avg Shares Out (Dil) | 102.00M | 101.10M | 93.08M | 84.54M | 25.37M | 2.96M |
Danimer Scientific: Biodegradable Plastics Are Still Important
Danimer Scientific Appoints Stephen Martin as Chief Legal Officer and Corporate Secretary
Danimer Scientific CEO Stephen Croskrey to Take Part in White House-Hosted Summit on Biotechnology and Biomanufacturing
Danimer Scientific to Attend Credit Suisse 35th Annual Specialties and Basics Conference
Danimer Scientific (DNMR) Q2 2022 Earnings Highlights
Danimer Scientific, Inc. (DNMR) CEO Stephen Croskrey on Q2 2022 Results Earnings Call Transcript
Danimer Scientific Announces Second Quarter 2022 Results
Danimer Scientific Announces Date for Second Quarter 2022 Results
Danimer Scientific Invited to Submit Part II Application for DOE Loan Guarantee
Danimer Scientific to Attend Cowen's 2nd Annual Sustainability & Energy Transition Summit
Source: https://incomestatements.info
Category: Stock Reports